Tom Y. Lee - 20 Aug 2024 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: PURE
Reported as of: 20 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Aug 2024, 18:00:36 UTC
Prior SEC filing: 03 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Tom Y. Lee

Key filing fact

Tom Y. Lee filed Form 4 for PURE BIOSCIENCE, INC. (PURE) on 22 Aug 2024.

Key facts

This page summarizes Tom Y. Lee's Form 4 filing for PURE BIOSCIENCE, INC. (PURE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Aug 2024, 18:00.

Change

Previous filing in this sequence was filed on 03 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PURE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +125,000
Change %
Price: $0.000000
Shares after: 125,000
Date: 20 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 125,000
Exercise price: $0.0700
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026.